Study guide
2.1 OSHA Bloodborne Pathogens & Sharps Safety
National Certified Patient Care Technician NCPCT
Track your progress as you read
Finished sections get a check mark.
1 Introduction: The NCPCT Exam
About the NCPCT Exam
2 Chapter 1: Infection Control Foundations & Precautions
1.1 Hand Hygiene & Standard Precautions 1.2 Personal Protective Equipment (PPE) Protocols 1.3 Transmission-Based Precautions 1.4 Cleaning & Disinfecting Equipment and the Patient Environment
3 Chapter 2: OSHA Safety, Biohazards & Emergency Response
2.1 OSHA Bloodborne Pathogens & Sharps Safety 2.2 Fall Prevention, Environmental Safety & Emergency Protocols 2.3 First Aid, Choking, Rapid Response & Emergency Codes
4 Chapter 3: Patient Intake, Identification & Vital Signs
3.1 Patient Identification & Admission, Transfer, Discharge 3.2 Vital Signs Measurement & Clinical Alerts 3.3 Recognizing, Reporting & Documenting Changes in Condition
5 Chapter 4: Daily Patient Care & Basic Nursing Skills
4.1 Activities of Daily Living (ADLs) & Dysphagia Care 4.2 Grooming, Dressing & Shower Safety 4.3 Bed Making, Room Supplies & Visual Inspection of Specimens 4.4 Urinary Catheter & Ostomy Care 4.5 Fluid Balance, Intake & Output (I&O) & Peripheral IV Monitoring
6 Chapter 5: Peripheral IV & Enteral Tube Care
5.1 Peripheral IV Insertion & Removal 5.2 Nasogastric & Gastrostomy Tube Care
7 Chapter 6: Skin, Wound & Restorative Care
6.1 Skin Integrity, Pressure Injury Prevention & Mobility 6.2 Wound Drainage Observation & Simple Dressing Changes 6.3 Restorative Care: Ambulation Aids and Bladder & Bowel Retraining 6.4 Splints, Elastic Bandages, Orthotic & Prosthetic Devices 6.5 Adapting Care for Patients With Special Needs
8 Chapter 7: Specimens, Respiratory Support & Perioperative Care
7.1 Non-Blood Specimen Collection & Handling 7.2 Oxygen Therapy & Respiratory Care Support 7.3 Nebulizer Treatments, Oral Suctioning & Airway Clearance 7.4 Pre-operative, Post-operative & Postmortem Care
9 Chapter 8: Phlebotomy Equipment & CLSI Order of Draw
8.1 Venipuncture Equipment & Evacuated Tube System (ETS) 8.2 CLSI Order of Draw & Inversion Protocols
10 Chapter 9: Venipuncture Procedures & Complications
9.1 Antecubital Anatomy, Vein Selection & Venipuncture Technique 9.2 Venipuncture Complications, Special Sites & Troubleshooting 9.3 Venipuncture Across the Lifespan: Children, Older Adults & Other Special Populations
11 Chapter 10: Capillary Collection & Specimen Processing
10.1 Capillary Punctures & Dermal Microcollection 10.2 Specimen Handling, Special Transport & Processing
12 Chapter 11: Cardiac Conduction, Lead Placement & Special Considerations
11.1 Cardiac Electrophysiology & ECG Paper Calibration 11.2 Standard 12-Lead Electrode Placement & Special Placements 11.3 Pacemakers, ICDs, Holter Hookup & Other Special ECG Considerations
13 Chapter 12: Waveform Analysis, Arrhythmias & Telemetry
12.1 ECG Waveforms, Segments & Normal Intervals 12.2 Cardiac Arrhythmia Recognition & Emergency Rhythms 12.3 Premature Beats (PACs, PJCs, PVCs), SVT & AV Heart Blocks 12.4 ECG Artifact Troubleshooting & Continuous Monitoring
14 Chapter 13: Healthcare Law & Scope of Practice
13.1 PCT Scope of Practice & Delegation Principles 13.2 HIPAA Compliance, Patient Privacy & Record Security
15 Chapter 14: Patient Rights, Ethics & Reporting
14.1 Patient Rights, Autonomy & Advance Directives 14.2 Ethical Practice, Abuse Reporting & Incident Documentation 14.3 Responding to Unethical or Unlawful Practice, Negligence & Impaired Coworkers
2.1 OSHA Bloodborne Pathogens & Sharps Safety
Key Takeaways Explain This Topic AI
The OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030) mandates that healthcare facilities maintain a written Exposure Control Plan updated annually with non-managerial frontline employee input.
Average percutaneous transmission risks differ sharply: about 6% to 30% for hepatitis B in a nonimmune worker, about 0.2% for hepatitis C (CDC 2020 guidance), and about 0.3% for HIV.
Engineering controls such as self-sheathing needles and retractable lancets physically isolate or remove hazards, whereas work practice controls alter operational behaviors, including the strict prohibition of two-handed recapping.
Rigid, puncture-resistant biohazard sharps containers must be permanently locked and replaced when two-thirds to three-quarters (2/3 to 3/4) full, and sharps must never be forced past resistance.
After a needlestick, wash the wound with soap and water, report to the charge nurse at once, complete an exposure report, and get a medical evaluation right away so HIV PEP, if indicated, starts within hours.
Last updated: September 2026
OSHA Bloodborne Pathogens & Sharps Safety
Core Clinical Principle: Protecting healthcare personnel and patients from bloodborne pathogen transmission requires strict compliance with federal occupational safety regulations, consistent deployment of safety-engineered devices, disciplined disposal of contaminated sharps, and rapid execution of post-exposure decontamination protocols.
Working as a Patient Care Technician (PCT) involves routine, direct contact with blood, bodily fluids, and invasive clinical equipment. Percutaneous injuries from contaminated needles and sharps represent one of the most serious occupational hazards in acute and ambulatory care settings. Mastering regulatory standards, transmission risks, and control measures is essential for clinical safety and patient care certification.
1. The OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030)
Promulgated by the Occupational Safety and Health Administration (OSHA) , the Bloodborne Pathogens Standard ( 29 CFR 1910.1030 ) establishes legally binding mandates designed to protect workers from health hazards associated with bloodborne pathogens and Other Potentially Infectious Materials (OPIM).
The Exposure Control Plan (ECP)
Every healthcare employer must create, maintain, and implement an institutional Exposure Control Plan (ECP) . Key regulatory mandates governing the ECP include:
Annual Review and Updates: The ECP must be reviewed and formally updated at least annually, or whenever workplace procedures, job classifications, or technological innovations (such as new safety-engineered sharps devices) change.
Frontline Staff Input: In accordance with the Needlestick Safety and Prevention Act, employers must solicit and document meaningful input from non-managerial clinical employees—including PCTs and phlebotomists—regarding the identification, evaluation, and selection of effective engineering and work practice controls.
Universal Accessibility: The written ECP must be accessible to all employees at all times during every work shift (whether in physical binders at nursing stations or through the facility intranet).
Exposure Determination: A comprehensive listing of all job classifications, tasks, and procedures in which occupational exposure occurs without regard to personal protective equipment (PPE).
Defining Blood and OPIM
Under OSHA definitions, clinical precautions apply to blood and specific body fluids:
Regulated Materials (Blood & OPIM): Human blood, blood components, products made from human blood, semen, vaginal secretions, cerebrospinal fluid (CSF), synovial fluid, pleural fluid, pericardial fluid, peritoneal fluid, amniotic fluid, saliva in dental settings, any bodily fluid visibly contaminated with blood, and all body fluids in situations where it is difficult or impossible to differentiate between fluids.
Non-OPIM Materials (Unless Visually Bloody): Tears, sweat, non-bloody saliva, non-bloody nasal secretions, non-bloody sputum, non-bloody vomitus, non-bloody urine, and non-bloody feces. While these materials are handled with Standard Precautions for general hygiene, they do not trigger the Bloodborne Pathogens Standard unless visible blood is present.
2. Primary Bloodborne Pathogens of Concern
Healthcare workers encounter three primary viral pathogens transmitted through percutaneous injuries, splashes to mucous membranes, or non-intact skin contact.
Hepatitis B Virus (HBV)
Transmission Risk: Highest among the three major viruses. After a percutaneous injury from an HBV-infected source, the risk of infection in a nonimmune worker is commonly cited as 6% to 30% ; the risk sits at the high end when the source patient is hepatitis B e-antigen (HBeAg) positive.
Environmental Viability: HBV is an exceptionally resilient enveloped virus capable of surviving in dried blood on environmental surfaces, counters, and medical equipment at room temperature for at least 7 days .
Vaccination Mandate: OSHA mandates that employers offer the Hepatitis B vaccination series (for example, the traditional 3-dose schedule at 0, 1, and 6 months, or a 2-dose adult vaccine such as Heplisav-B) to all employees with potential occupational exposure at no cost , during work hours, within 10 working days of initial assignment.
Post-Vaccination Titers: Healthcare workers must undergo serologic testing for Hepatitis B surface antibodies (anti-HBs) 1 to 2 months after completing the third dose to confirm immunity.
Mandatory Declination Form: An employee has the legal right to decline the vaccine. However, if declined, the employee must sign the official OSHA Hepatitis B Vaccine Declination Form. If the employee later decides to accept the vaccine while still covered under the standard, the employer must provide it immediately without financial cost.
Hepatitis C Virus (HCV)
Transmission Risk: Older textbooks cite about 1.8% after a percutaneous exposure to HCV-positive blood. CDC's 2020 guidance for exposed health care personnel uses a more recent estimate of about 0.2% for percutaneous exposures and essentially 0% for mucous membrane exposures.
Clinical Characteristics: HCV is the most common chronic bloodborne infection in the United States. Between 70% and 85% of individuals infected with acute HCV progress to chronic hepatitis, with long-term complications including cirrhosis and hepatocellular carcinoma.
Vaccine and Treatment Status: There is no vaccine available for Hepatitis C. Modern management utilizes direct-acting antiviral (DAA) medications. Baseline and serial post-exposure antibody (anti-HCV) and HCV RNA assays are performed following occupational exposure.
Human Immunodeficiency Virus (HIV)
Transmission Risk: The average risk of HIV seroconversion after an occupational percutaneous exposure to HIV-infected blood is approximately 0.3% (1 in 300). Following a mucous membrane exposure (such as a splash to the eyes or mouth), the transmission risk drops to approximately 0.09% (less than 1 in 1,000).
Environmental Viability: HIV is fragile and dries out rapidly outside living hosts; it loses infectious titer rapidly upon drying compared to HBV.
Post-Exposure Prophylaxis (PEP): Highly effective antiretroviral drug combinations should be started as soon as possible—ideally within hours of the exposure (many employee health protocols aim for about 2 hours), and generally no later than 72 hours—and continued for 28 days .
Comparison Table: Major Bloodborne Viruses
Clinical Parameter Hepatitis B Virus (HBV) Hepatitis C Virus (HCV) Human Immunodeficiency Virus (HIV)
Percutaneous Transmission Risk 6% to 30% (nonimmune worker) About 0.2% (CDC 2020; older sources cite 1.8%) Approximately 0.3% (1 in 300)
Mucous Membrane Transmission Risk Documented, moderate Rare (< 0.1%) Approximately 0.09% (1 in 1,000)
Environmental Stability High (survives >= 7 days dry) Moderate (can stay infectious on surfaces for days or longer) Very low (inactivated rapidly upon drying)
Vaccine Availability Yes (3-dose recombinant series; free) No vaccine available No vaccine available
Post-Exposure Prophylaxis (PEP) Hepatitis B Immune Globulin (HBIG) + vaccine No approved PEP; monitor RNA / DAA therapy 28-day antiretroviral combination therapy
Optimal Window for PEP Within 24 hours (up to 7 days) N/A (early monitoring) As soon as possible, ideally within hours (no later than 72 hours)
3. Engineering Controls vs. Work Practice Controls
The Needlestick Safety and Prevention Act of 2000 revised the OSHA standard to place primary emphasis on engineering controls to eliminate needle and sharp injuries. HIERARCHY OF SHARPS CONTROLS
- ┌─────────────────────────────────────────────────────────────┐
- │ 1. Engineering Controls (Built-in Device Safety Mechanisms) │
- │ - Retractable needles, self-blunting trocars, safety hubs │
- └──────────────────────────────┬──────────────────────────────┘
- ▼
- ┌─────────────────────────────────────────────────────────────┐
- │ 2. Work Practice Controls (Behavioral Protocols) │
- │ - Immediate point-of-use disposal, no two-handed recap │
- └──────────────────────────────┬──────────────────────────────┘
- ▼
- ┌─────────────────────────────────────────────────────────────┐
- │ 3. Personal Protective Equipment (Barrier Defense) │
- │ - Nitrile gloves, splash goggles, face shields, gowns │
- └─────────────────────────────────────────────────────────────┘
- Engineering Controls
Engineering controls isolate, shield, or eliminate the hazard directly through product design:
Self-Sheathing Needles: Needles equipped with a hinged plastic shield that snaps securely over the contaminated needle using a one-finger or flat-surface motion.
Retractable Lancets and Syringes: Devices containing spring-loaded mechanisms that automatically retract the sharp into the plastic housing upon full plunger depression or capillary puncture.
Blunt Cannula Systems: Needleless IV access ports and blunt transfer needles that replace traditional sharp metal needles for medication withdrawal and IV piggyback line connections.
Rigid Biohazard Sharps Disposal Units: Puncture-resistant, leak-proof containers mounted at points of care.
Work Practice Controls
Work practice controls alter the behavioral methods by which clinical tasks are performed:
Immediate Point-of-Use Disposal: Used needles, butterflies, and lancets must be dropped into a sharps container immediately after withdrawal from the patient. Never set contaminated sharps down on a bedside table, tray, or linen.
Prohibition of Two-Handed Recapping: Workers must never use two hands to guide a needle cap back onto a used needle. Two-handed recapping is a leading cause of needlestick injuries.
No Manipulation of Sharps: Bending, breaking, shearing, or manually unscrewing contaminated needles from reusable blood collection holders is strictly prohibited by federal regulation.
Food, Drink, and Cosmetic Restrictions: Eating, drinking, applying lip balm/cosmetics, and handling contact lenses are strictly prohibited in areas where blood or OPIM may be present (laboratories, clean utility rooms, phlebotomy stations, patient care bays).
The One-Handed Scoop Technique (Emergency Exception Only)
When recapping is strictly required by an unavoidable clinical protocol (such as transporting an arterial blood gas syringe on ice to a point-of-care analyzer when no needle-capping safety device is present), the worker must utilize the one-handed scoop technique :
Place the needle cap horizontally on a flat, stable surface.
Holding the syringe with one hand only, gently insert the needle tip into the open cap opening without touching the cap.
Slide the needle completely into the cap until the cap covers the needle shaft.
Tip the syringe upright so the cap drops down over the hub, and press the base of the cap firmly against a vertical surface or snap it shut using only the holding hand. Never bring the non-dominant hand into proximity with the capped needle.
4. Sharps Disposal Containers and Safety Rules
Disposal containers are precision engineering tools that prevent punctures and cross-contamination:
Container Specifications
Physical Properties: Containers must be rigid, puncture-resistant, leak-proof on the sides and bottom, and sealable.
Labeling: Marked with the universal biohazard symbol and the word "BIOHAZARD" in prominent, contrasting fluorescent orange-red or red lettering.
Mounting Height: Sharps containers should be mounted at eye level, approximately 52 to 56 inches above the floor, allowing the user to view the contents and fill line clearly while standing.
Capacity and Replacement Rules
The 2/3 to 3/4 Rule: Sharps containers must be closed, permanently locked, and replaced when they reach the manufacturer's fill line, or when they are two-thirds (2/3) to three-quarters (3/4) full .
Never Force Sharps: Never force, ram, or shake a needle into an overfilled container. If resistance is met, stop immediately.
No Retrieving or Shaking: Personnel must never reach into, manipulate, shake to settle contents, or manually empty a sharps container. Once full, seal the lid permanently and route the container through regulated medical waste transport.
5. Step-by-Step Immediate Post-Exposure Protocol
When a percutaneous needlestick, scalpel cut, or splash of blood/OPIM occurs, every second counts. The technician must follow a standardized emergency clinical sequence: IMMEDIATE POST-EXPOSURE PROTOCOL
- ┌─────────────────────────────────────────────────────────────┐
- │ STEP 1: Decontaminate Wound or Mucous Membranes Immediately │
- │ - Percutaneous: Wash promptly with soap and running water │
- │ - Splash: Flush eyes/mucosa with water or saline for 15 min│
- └──────────────────────────────┬──────────────────────────────┘
- ▼
- ┌─────────────────────────────────────────────────────────────┐
- │ STEP 2: Immediately Notify Charge Nurse / Supervisor │
- │ - Secure immediate relief from duty to undergo evaluation │
- └──────────────────────────────┬──────────────────────────────┘
- ▼
- ┌─────────────────────────────────────────────────────────────┐
- │ STEP 3: Complete Incident / Exposure Documentation │
- │ - Device type, mechanism, fluid volume, patient identity │
- └──────────────────────────────┬──────────────────────────────┘
- ▼
- ┌─────────────────────────────────────────────────────────────┐
- │ STEP 4: Medical Evaluation & Baseline Serologic Testing │
- │ - Source patient consented testing (HIV, HBV, HCV) │
- │ - Employee baseline blood draw (anti-HBs, anti-HCV, HIV) │
- └──────────────────────────────┬──────────────────────────────┘
- ▼
- ┌─────────────────────────────────────────────────────────────┐
- │ STEP 5: Post-Exposure Prophylaxis (PEP) Initiation │
- │ - Start HIV PEP within hours if clinically indicated │
- │ - Administer HBIG / vaccine booster if HBV unprotected │
- └─────────────────────────────────────────────────────────────┘
- Clinical Steps Breakdown
Step 1: Immediate Decontamination:
Skin puncture or laceration: Wash the wound promptly and thoroughly with soap and running water. CDC does not set a required number of minutes; follow your facility's exposure protocol. Let the water flow freely over the puncture. Do not squeeze, pinch, or "milk" the puncture wound, as mechanical compression causes localized tissue trauma that facilitates viral entry into capillaries. Never use harsh chemical caustics (e.g., bleach, iodine tincture, or alcohol concentrated rubs) in the wound bed.
Eye or mucous membrane splash: Immediately proceed to an emergency eyewash station. Hold eyelids open with clean fingers and flush continuously with copious amounts of clean running water or normal saline for a minimum of 15 minutes . Remove contact lenses during irrigation.
Step 2: Immediate Supervisor Notification:
Immediately notify the charge nurse, preceptor, or clinical supervisor. Ensure clinical coverage for current patients so the technician can seek immediate medical care.
Step 3: Document Incident Specifics:
Complete the facility's formal Occupational Exposure / Incident Report. Document the exact date, time, clinical department, type and brand of sharp device, gauge, whether the safety mechanism was deployed, depth of penetration, fluid involved, and the identity of the source patient.
Step 4: Medical Evaluation and Baseline Testing:
Proceed directly to Employee Health or the Emergency Department. With informed consent (subject to state laws), the source patient is tested for HIV antibody/antigen, Hepatitis B surface antigen (HBsAg), and Hepatitis C antibody (anti-HCV).
The exposed technician undergoes baseline testing for HIV, anti-HBs (Hepatitis B surface antibody), and anti-HCV to prove non-infection prior to the incident.
Step 5: Post-Exposure Prophylaxis (PEP) Administration:
If the source patient is HIV-positive or of high-risk unknown status, multi-drug antiretroviral PEP should be started as soon as possible—ideally within hours—and taken for 28 days.
For HBV exposure, if the worker is an unimmunized non-responder, Hepatitis B Immune Globulin (HBIG) and the HBV vaccine series are initiated within 24 hours.
6. Waste Segregation: Regulated Medical Waste vs. Regular Trash
Improper sorting of healthcare waste endangers environmental services staff and increases disposal costs. OSHA and the EPA strictly define what constitutes Regulated Medical Waste (RMW) .
Waste Category Typical Clinical Items Proper Disposal Receptacle Handling Mandates
Regulated Medical Waste (Biohazard) Blood-soaked dressings that release liquid when compressed; suction canisters with free-flowing bloody fluid; surgical tissue specimens; microbiological culture plates. Heavy-duty, leak-proof Red Biohazard Bags marked with universal biohazard symbol. Double-bagged if outer surface becomes contaminated; kept in rigid outer holding tubs.
Sharps Waste Needles, scalpels, lancets, broken glass blood tubes, glass ampules, suture needles, butterfly wings. Rigid, puncture-resistant Biohazard Sharps Containers . Replace when 2/3 to 3/4 full; seal permanently before transit.
Non-Regulated Municipal Trash Examination gloves with routine dust/dirt; dressings with minor pinpoint spotting; dry, caked non-flaking drops; empty urine bags; non-bloody disposable bed pads; plastic packaging. Standard Clear, Black, or Brown Trash Liners . Disposed of via standard municipal landfill; do not needlessly use expensive red biohazard bags.
Pathological / Chemotherapy Waste Tissue specimens, chemotherapy bags, IV tubing used for antineoplastic agents. Yellow Bags/Containers (trace chemo) or labeled pathological bins. Incinerated under specialized hazardous waste permits.
- 7. Clinical Traps & Healthcare Scenarios
- Clinical Trap 1: Milking a Needlestick Wound
The Error: Squeezing, pinching, or suctioning a needlestick wound to force blood out.
The Clinical Reality: Milking traumatizes the microvascular endothelium and induces local hyperemia, drawing potential virions deeper into capillary beds and lymphatic channels. Always wash promptly with soap and running water without squeezing.
Clinical Trap 2: Discarding Blood Tube Holders with Needles Attached into Trash
The Error: Attempting to save money or time by unscrewing a used multi-sample needle from a plastic tube holder, or tossing the entire assembly into standard trash.
The Clinical Reality: OSHA strictly forbids removing needles from tube holders manually. The entire needle-and-holder combination must be discarded as a single, intact unit into the sharps container immediately after venipuncture.
Clinical Trap 3: Two-Handed Recapping During Phlebotomy Distractions
The Error: A patient jolts during needle withdrawal, and the technician holds the needle cap in one hand while guiding the needle with the other.
The Clinical Reality: Hand-eye coordination failures under stress cause the needle to slip past the cap opening and penetrate the supporting fingers. Always engage the built-in hinged safety cover using a one-finger or surface-push technique, or discard unsheathed directly into the nearest sharps box.